samedan logo
 
 
 
spacer
home > pmps > summer 2019 > a seamless supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Seamless Supply

Clinical trials can vary in their scope and design and can be either single-site or multi-site, happening in a single country or in several geographical areas. In some clinical areas, studies are becoming larger and more complex, while the sponsors desire faster recruitment and data generation. Multi-site, multi-country studies are challenging as they require the coordination of many different parameters such as manufacturing, packaging, temperature management, storage, and distribution.

Clinical trials usually comprise three different stages: the study preparation, the active study (between ‘first patient, first visit’ and ‘last patient, last visit’) and the finalisation of the study (after ‘last patient, last visit’). Each of these stages will face different challenges of the logistics and supply chain that must be controlled.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Celine Chanforan graduated with a Masters in Food Science from the University of Montpellier, France, in 2006, and achieved her PhD in Food Chemistry from the University of Avignon, France, in 2010. Celine started her career as Project Manager in the food ingredient sector for nine years. Celine mainly managed R&D projects for food colours and dietary supplements. After moving to the UK in 2016, Celine has been in charge of projects related to the delivery of new immunoassay tests for various applications and in accordance with in vitro diagnostic quality management system ISO 13485. In 2017, Celine joined Onorach as Clinical Project Manager and is now in charge of the international clinical project portfolio.
spacer
Celine Chanforan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Protagen Protein Services (PPS) expands capabilities for aggregate analytics to include dynamic light scattering (DLS)

Protein aggregation is a common challenge in the manufacturing of biological products. As one of the most sensitive techniques for the detection of aggregates, dynamic light scattering (DLS) provides a simple, fast and non-destructive testing method. An innovative technique based on a unique cuvette layout allows for accurate measurements with as little as a single µL of solution.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement